The presentation by Salma Patel, MD, MPH, discusses a recent study in the Journal of Respiratory Critical Care Medicine. It suggests adaptive servo-ventilation (ASV) may still be a treatment option for patients with complex sleep apnea. A past study suggested that ASV therapy had significantly higher all-cause and cardiovascular mortality. This new study concludes that the past results may have been a device-effect and not a class-effect.

This content is paid for by:

PhilipsRespironics

Partner with Sleep Review on content marketing.